Dr. Jia Li, MD, PhD

Dr. Li practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Li's NPI, 1083879134, was assigned on July 28, 2008. Dr. Li graduated from Tianjin Medical University in 1995. Dr. Li's New York license number on file is 257431.

Dr. Li's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Li's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Li is also affiliated with Norwalk Hospital. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Li to 2 more medical groups, each named with a free account. Dr. Li's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Li is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Li's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists colorectal cancer, lung cancer and prostate cancer among the conditions Dr. Li treats.

CMS data shows 1,086 Medicare services from Dr. Li across 3 procedure codes in 2024, all of them office visits, for 359 Medicare patients. Medicare paid $100,668 for them. Every service was in an office.

CMS counts 359 Medicare patients who saw Dr. Li in 2024. The largest group is 75 to 84, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 74, with 45% women.

In 2024, Dr. Li wrote 1,098 Medicare Part D claims for 205 patients. 80% of them were for generic drugs. CMS names the drug for 924 of them, across 28 drugs with 11 or more claims each, at $487,640 in total drug cost. In 2023, CMS named 665 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Li for performance year 2024, reported as part of a group. Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Li as offering telehealth.

Dmand AI links 34 papers to Dr. Li, published from 2009 to 2022. 2013 was the busiest year, with 2. The most frequent topics are Pancreatic Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Fluorouracil. Dr. Li has published most often in JOP. Dr. Li's most frequent co-authors are Geoffrey Yuyat Ku, MD, David H. Ilson, MD and David P. Kelsen, MD.

CMS Open Payments shows 2 general payments to Dr. Li from 2 drug and device companies in 2018. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $45.

Dr. Li graduated from Tianjin Medical University in 1995.

Dr. Li is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.